Lars‐Eric Lins

975 total citations
33 papers, 712 citations indexed

About

Lars‐Eric Lins is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lars‐Eric Lins has authored 33 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lars‐Eric Lins's work include Dialysis and Renal Disease Management (8 papers), Urinary Bladder and Prostate Research (4 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). Lars‐Eric Lins is often cited by papers focused on Dialysis and Renal Disease Management (8 papers), Urinary Bladder and Prostate Research (4 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). Lars‐Eric Lins collaborates with scholars based in Sweden, United States and Canada. Lars‐Eric Lins's co-authors include Stefan H. Jacobson, Bengt E. Karlberg, Karin Hermansson, Naomi Clyne, S. KENNETH PEHRSSON, Jan Winberg, I. Wikstad, Jonas Berglund, Per‐Eric Lins and Carl M. Kjellstrand and has published in prestigious journals such as The Lancet, Kidney International and The Journal of Urology.

In The Last Decade

Lars‐Eric Lins

33 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars‐Eric Lins Sweden 14 192 152 146 131 123 33 712
Martin Kirschstein Germany 13 294 1.5× 206 1.4× 330 2.3× 86 0.7× 147 1.2× 28 1.0k
James E. Springate United States 17 159 0.8× 253 1.7× 90 0.6× 58 0.4× 93 0.8× 64 954
Emre Tutal Türkiye 18 234 1.2× 52 0.3× 131 0.9× 78 0.6× 198 1.6× 68 989
R. Morrison Hurley United States 15 221 1.2× 111 0.7× 65 0.4× 65 0.5× 108 0.9× 46 728
John E. Lewy United States 17 270 1.4× 229 1.5× 34 0.2× 37 0.3× 83 0.7× 44 735
Marinus H. de Keijzer Netherlands 13 118 0.6× 90 0.6× 122 0.8× 38 0.3× 229 1.9× 35 598
U. Ott Germany 19 302 1.6× 137 0.9× 44 0.3× 90 0.7× 141 1.1× 44 886
K Huttunen Finland 14 166 0.9× 97 0.6× 73 0.5× 41 0.3× 137 1.1× 23 631
Hassib Chehade Switzerland 15 326 1.7× 346 2.3× 57 0.4× 109 0.8× 81 0.7× 60 896
J. A. Whitworth Australia 12 117 0.6× 66 0.4× 106 0.7× 44 0.3× 65 0.5× 33 500

Countries citing papers authored by Lars‐Eric Lins

Since Specialization
Citations

This map shows the geographic impact of Lars‐Eric Lins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars‐Eric Lins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars‐Eric Lins more than expected).

Fields of papers citing papers by Lars‐Eric Lins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars‐Eric Lins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars‐Eric Lins. The network helps show where Lars‐Eric Lins may publish in the future.

Co-authorship network of co-authors of Lars‐Eric Lins

This figure shows the co-authorship network connecting the top 25 collaborators of Lars‐Eric Lins. A scholar is included among the top collaborators of Lars‐Eric Lins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars‐Eric Lins. Lars‐Eric Lins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johansson, Maja, et al.. (2018). GR3027 reversal of neurosteroid-induced, GABA-A receptor-mediated inhibition of human brain function: an allopregnanolone challenge study. Psychopharmacology. 235(5). 1533–1543. 15 indexed citations
2.
3.
Karlberg, Bengt E., Lars‐Eric Lins, & Karin Hermansson. (1999). Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. Journal of Hypertension. 17(2). 293–302. 90 indexed citations
4.
Fernvik, Eva, et al.. (1996). Monocyte and Granulocyte CD11 b/CD18, CD62L Expression and slCAM-1 Concentration in the Interdialytic Period. Nephron. 74(2). 275–282. 13 indexed citations
5.
Clyne, Naomi, Nils Egberg, & Lars‐Eric Lins. (1995). Effects of hemodialysis and longterm erythropoietin treatment on protein C, and on free and total protein S. Thrombosis Research. 80(2). 161–168. 7 indexed citations
6.
Jacobson, Stefan H., et al.. (1994). Acute Symptoms During and Between Hemodialysis: The Relative Role of Speed, Duration, and Biocompatibility of Dialysis. Artificial Organs. 18(12). 880–887. 29 indexed citations
7.
Jacobson, Stefan H., et al.. (1992). Long-term prognosis of post-infectious renal scarring in relation to radiological findings in childhood ? a 27-year follow-up. Pediatric Nephrology. 6(1). 19–24. 105 indexed citations
8.
Ljungqvist, Olle, G. Hedenborg, Stefan H. Jacobson, et al.. (1990). Whole body impedance measurements reflect total body water changes. A study in hemodialysis patients. International journal of clinical monitoring and computing. 7(3). 163–169. 4 indexed citations
9.
Clyne, Naomi, Tomas Jogestrand, Lars‐Eric Lins, & S. KENNETH PEHRSSON. (1989). Factors Influencing Physical Working Capacity in Renal Transplant Patients. Scandinavian Journal of Urology and Nephrology. 23(2). 145–150. 9 indexed citations
10.
Jacobson, Stefan H., David S. Fryd, Lars‐Eric Lins, et al.. (1988). Transplantation, hemodialysis, and continuous ambulatory peritoneal dialysis for end-stage renal disease in diabetic patients. Journal of Diabetic Complications. 2(3). 150–157. 6 indexed citations
11.
Jacobson, Stefan H. & Lars‐Eric Lins. (1988). Renal Hemodynamics and Blood Pressure Control in Patients with Pyelonephritic Renal Scarring. Acta Medica Scandinavica. 224(1). 39–45. 4 indexed citations
12.
Nilsson‐Ehle, Peter, et al.. (1988). Lipoproteins and Metabolic Control in Hypertensive Type II Diabetics Treated with Clonidine. Acta Medica Scandinavica. 224(2). 131–134. 5 indexed citations
13.
Jacobson, Stefan H., Gunilla Källenius, Lars‐Eric Lins, & Stefan B. Svenson. (1988). P-Fimbriae Receptors in Patients with Chronic Pyelonephritis. The Journal of Urology. 139(5). 900–903. 5 indexed citations
14.
Jacobson, Stefan H., Carl M. Kjellstrand, & Lars‐Eric Lins. (1988). Role of Hypervolemia and Renin in the Blood Pressure Control of Patients with Pyelonephritic Renal Scarring. Acta Medica Scandinavica. 224(1). 47–53. 7 indexed citations
15.
Berglund, Jonas, Per‐Eric Lins, Ulf Adamson, & Lars‐Eric Lins. (1987). Microalbuminuria in Long‐term Insulin‐dependent Diabetes Mellitus. Acta Medica Scandinavica. 222(4). 333–338. 26 indexed citations
16.
Jacobson, Stefan H., N Lindvall, & Lars‐Eric Lins. (1987). Renal Size, Glomerular Function and Urinary Excretion of Albumin and β2‐Microglobulin in Patients with Renal Scarring Due to Pyelonephritis. Acta Medica Scandinavica. 222(3). 261–266. 8 indexed citations
17.
Clyne, Naomi, Tomas Jogestrand, Lars‐Eric Lins, S. KENNETH PEHRSSON, & Lars‐Göran Ekelund. (1987). Factors Limiting Physical Working Capacity in Predialytic Uraemic Patients. Acta Medica Scandinavica. 222(2). 183–190. 30 indexed citations
18.
Pehrsson, Kenneth & Lars‐Eric Lins. (1983). The Role of Trace Elements in Uremic Heart Failure. ˜The œNephron journals/Nephron journals. 34(2). 93–98. 15 indexed citations
19.
Eliasson, Keith, et al.. (1979). VASOSPASTIC PHENOMENA IN PATIENTS TREATED WITH BETA‐ADRENOCEPTOR BLOCKING AGENTS. Acta Medica Scandinavica. 205(S628). 39–46. 8 indexed citations
20.
Lins, Lars‐Eric, et al.. (1971). Y/E Index in a Swedish Population. Acta geneticae medicae et gemellologiae. 20(2). 211–216. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Kirschstein Breakdown of academic impact, for papers by James E. Springate Breakdown of academic impact, for papers by Emre Tutal Breakdown of academic impact, for papers by R. Morrison Hurley Breakdown of academic impact, for papers by John E. Lewy Breakdown of academic impact, for papers by Marinus H. de Keijzer Breakdown of academic impact, for papers by U. Ott Breakdown of academic impact, for papers by K Huttunen Breakdown of academic impact, for papers by Hassib Chehade Breakdown of academic impact, for papers by J. A. Whitworth
Rankless by CCL
2026